Progression-free survival results in postmenopausal Asian women: subgroup analysis from a phase III randomized trial of fulvestrant 500 mg vs anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON) |
| |
摘 要: |
|
本文献已被 SpringerLink 等数据库收录! |
|